Potential systemic effects of acquired CFTR dysfunction in COPD
Marc Miravitlles(Vall d'Hebron Institut de Recerca), Pablo Altman(Novartis (United States))
Cited by 11
Related Papers
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679
An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2015|217
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
|European Respiratory Journal|2015|203